Top

Abigail S. Caudle, M.D., M.S., F.A.C.S., CMQ

Department of Breast Surgical Oncology, Division of Surgery

Present Title & Affiliation

Primary Appointment

Professor, Department of Breast Surgical Oncology, Division of Surgery, MD Anderson Cancer Center, Houston, Texas

Vice President, Department of Procedural & Theraptc Prac, Ofc of Chief Operating Officer, The University of Texas MD Anderson Cancer Center, Houston, Texas

Associate Professor, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Vice President, Department of Procedural & Theraptc Prac, Ofc of Chief Operating Officer, The University of Texas MD Anderson Cancer Center, Houston, Texas

Associate Professor, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2023	Harvard University T.S Chan School of Public Health, Boston, Massachusetts, US, Masters of Health Care Management, MHCM
2013	University of Michigan School of Public Health, Ann Arbor, Michigan, US, Clinical Research Design and Statistical Analysis, M.S
2000	University of North Carolina School of Medicine, Chapel Hill, North Carolina, US, MD
1995	University of North Carolina, Chapel Hill, North Carolina, US, Biology and Chemistry, BS

Postgraduate Training

2008-2009	Research Fellowship, Surgical Oncology Research, NIH T-32 Training Grant, The University of Texas MD Anderson Cancer Center, Houston, Texas
2007-2010	Clinical Fellowship, Surgical Oncology Fellow, The University of Texas MD Anderson Cancer Center, Houston, Texas
2005-2007	Research Fellowship, Surgical Oncology, NIH T-32 Training Grant, University of North Carolina, Chapel Hill, North Carolina
2000-2005	Clinical Residency, General Surgery, University of North Carolina, Chapel Hill, North Carolina

Board Certifications

2015	American Board of Medical Quality (Certification)
2006	American Board of Surgery

Experience & Service

Academic Appointments

Assistant Professor, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2016

Administrative Appointments/Responsibilities

Member, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present

Vice President, Department of Procedural & Theraptc Prac, Ofc of Chief Operating Officer, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present

Associate Vice President & Executive Medical Director, Department of Perioperative, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2020

Executive Medical Director, Department of Perioperative Services, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2019

Program Coordinator, Breast Surgical Oncology Morbidity & Mortality Conference, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - Present

Breast Surgical Oncology Quality Officer, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - Present

Program Leader, Department of Surgical Oncology, Interdisciplinary Breast Cancer Fellowship, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2015

Administrative Fellow, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2010

Administrative Chief Resident, Department of Surgery, University of North Carolina, Chapel Hill, NC, 2004 - 2005

Other Appointments/Responsibilities

Consultant, MD Anderson Physicians Network - Surgical Provider Quality Assessment, Houston, Texas, 2015 - Present

Assistant Anatomy Clinical Liaison, University of North Carolina School of Medicine, Chapel Hill, NC, 2006 - 2007

Anatomy Course Teaching Assistant, University of North Carolina School of Medicine, Chapel Hill, NC, 2005 - 2007

Institutional Committee Activities

Member, Beaker Pathology Transition Executive Steering Committee, 2022 - Present

Member, Supply Chain Executive Steering Committee, 2021 - Present

Member, Care Team Transformation Executive Steering Committee, 2021 - Present

Member, COVID Core Leadership Team, 2020 - Present

Member, Quality Assessment and Performance Improvement (QAPI) Council, 2020 - Present

Member, Institutional Patient Safety Committee, 2020 - Present

Member, Accreditation Readiness Committee, 2019

Member, Clinical Operations Leadership Team Steering Committee, 2018 - 2019

Member, Clinical Operations Leadership Team, 2018 - 2019

Member, Clinical Capital Equipment Committee, 2017 - Present

Committee Member, Integrated Clinical Practice Informatics Committee, 2016 - 2019

Member, Perioperative Informatics Committee, 2016 - Present

Committee Member, MD Anderson at Summit Relationship Committee, 2016 - 2019

Committee Member, Division of Surgery T32 Steering Committee, 2016 - 2017

Committee Member, Division of Surgery Gender Inclusiveness Committee, 2015 - 2023

Committee Member, Multi-Team Scheduling Task Force Committee, 2015 - 2017

Committee Member, Division of Surgery Continuous Quality Improvement Committee, 2014 - Present

Committee Member, Regional Care Center Surgeon OR Block Allocation Task Force, 2014 - 2015

Committee Member, Clinical Research Committee, 2014 - Present

Committee Member, Perioperative Enterprise Value Analysis Team, 2014 - Present

Committee Member, Surgical Oncology Fellowship Application Review Committee, 2014 - Present

Committee Member, OR Committee, 2014 - Present

Committee Member, MD Anderson at Cooper Relationship Committee, 2014 - Present

Member, Clinical Effort Standardization and Faculty Incentive Program Committee, 2013 - 2014

Committee Member, Faculty Senate Tenure and Promotions Committee, 2013 - 2019

Member, Faculty Senate Representative, 2013 - 2019

Program Leader, Interdisciplinary Breast Cancer Fellowship, 2012 - 2015

Committee Member, Surgical Oncology Curriculum Task Force, 2011 - 2012

Committee Member, OR Block Utilization Task Force, 2011 - Present

Committee Member, Patient Care Task Force, 2011 - 2012

Committee Member, Surgical Oncology Education Committee, 2010 - Present

Member, Administrative Fellow, 2008 - 2010

Honors & Awards

2015	Best Poster Session, European Society of Gynecology Oncology
2015	MD Anderson Clinical Innovator Award, The University of Texas MD Anderson Cancer Center
2012 - 2016	Rising Star - www.SuperDoctors.com
2012 - 2016	US News & World Report Top Doctor
2007	Translational Science Poster Award, Lineberger Comprehensive Cancer Center Scientific Retreat
2003	Outstanding Resident Award, Wake Medical Center, Raleigh, NC
2000	Academic Merit Award, University of North Carolina School of Medicine, Chapel Hill, NC
1992	North Carolina Merit Scholarship, University of North Carolina, Chapel Hill, NC

Professional Memberships

Society of Surgical Oncology

2015 - 2018

Alliance for Clinical Trials in Oncology

2015 - Present

Selected Publications

Peer-Reviewed Articles

Caudle AS, Moore AM, Sun SX, Yi M, Smith BD, Valero V, Yang W, Kuerer HM, Hunt KK, Teshome AM. Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes at Targeted Axillary Dissection, 2024.
Loveland-Jones, C, Gaughan, J, Caudle, AS, Murphy, BL, Samiian, L, Byrum, SC, Brill, K, Germaine, P, Zhang, X, Yoon-Flannery, K, Carter, T, Lopez, A, Gruner, R, Fantazzio, M, Kuerer, HM. Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registry. European Journal of Surgical Oncology 50(4), 2024. e-Pub 2024. PMID: 38484493.
Ma, C, Suman, VJ, Sanati, S, Vij, K, Anurag, M, Leitch, AM, Unzeitig, G, Hoog, J, Fernandez-Martinez, A, Fan, C, Gibbs, RA, Watson, M, Dockter, T, Hahn, OM, Guenther, JM, Caudle, AS, Crouch, EC, Tiersten, A, Mita, M, Razaq, W, Hieken, TJ, Wang, Y, Rimawi, MF, Weiss, A, Winer, EP, Hunt, KK, Perou, CM, Ellis, MJ, Partridge, AH, Carey, LA. Endocrine-Sensitive Disease Rate in Postmenopausal Patients with Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination. JAMA Oncology 10(3):362-371, 2024. e-Pub 2024. PMID: 38236590.
Diao, K, Lei, X, He, W, Jagsi, R, Giordano, SH, Smith, GL, Caudle, AS, Shen, Y, Peterson, SK, Smith, B. Racial and Ethnic Differences in Long-Term Adverse Radiation Therapy Effects Among Breast Cancer Survivors. International Journal of Radiation Oncology Biology Physics 118(3):626-631, 2024. e-Pub 2024. PMID: 37751792.
Farley, CR, Bassett Jr, R, Meric-Bernstam, F, Bedrosian, I, Caudle, AS, DeSnyder, SM, Hunt, KK, Kuerer, HM, Singh, P, Sun, SX, Tamirisa, N, Teshome, M, Hwang, RF. To Dissect or Not to Dissect. Annals of surgical oncology 30(13):8327-8334, 2023. e-Pub 2023. PMID: 37670121.
Diao, K, Lei, X, He, W, Jagsi, R, Giordano, SH, Smith, GL, Caudle, AS, Shen, Y, Peterson, SK, Smith, B. Patient-reported Quality of Life after Breast-conserving Surgery with Radiotherapy Versus Mastectomy and Reconstruction. Annals of surgery 278(5):E1096-E1102, 2023. e-Pub 2023. PMID: 37232937.
Zhang, Y, Zhao, Z, Huang, L, Liu, Y, Yao, J, Sun, C, Li, Y, Zhang, Z, Ye, Y, Yuan, F, Nguyen, TK, Garlapati, NR, Wu, A, Egranov, SD, Caudle, AS, Sahin, AA, Lim, B, Beretta, L, Calin, GA, Yu, D, Hung, MC, Curran, M, Rezvani, K, Gan, B, Tan, Z, Han, L, Lin, C, Yang, L. Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenation. Cell Metabolism 35(8):1457-1473.e13, 2023. e-Pub 2023. PMID: 37329887.
Caudle, AS. Invited Commentary. Surgery (United States) 174(2):419-421, 2023. e-Pub 2023. PMID: 37198035.
Sun, C, Ye, Y, Tan, Z, Liu, Y, Li, Y, Hu, W, Liang, K, Egranov, SD, Huang, L, Zhang, Z, Zhang, Y, Yao, J, Nguyen, TK, Zhao, Z, Wu, A, Marks, JR, Caudle, AS, Sahin, AA, Gao, J, Gammon, ST, Piwnica-Worms, D, Hu, J, Chiao, PJ, Yu, D, Hung, MC, Curran, M, Calin, GA, Ying, H, Han, L, Lin, C, Yang, L. Tumor-associated nonmyelinating Schwann cell-expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion. Science Advances 9(5), 2023. e-Pub 2023. PMID: 36724291.
Mehta, SN, Shenvi, EC, Blair, SL, Caudle, AS, Lowenstein, LM, Kelly, KJ. Leveraging the Multidisciplinary Tumor Board for Dissemination of Evidence-Based Recommendations on the Staging and Treatment of Gastric Cancer. Annals of surgical oncology 30(2):1120-1129, 2023. e-Pub 2023. PMID: 36222932.
Smith, B, Hanson, SE, Lei, X, Roubaud, MJ, DeSnyder, SM, Caudle, AS, Shaitelman, SF, Hoffman, K, Smith, GL, Jagsi, R, Peterson, SK. Long-Term Quality of Life in Patients with Breast Cancer after Breast Conservation vs Mastectomy and Reconstruction. JAMA Surgery 157(6), 2022. e-Pub 2022. PMID: 35416926.
Elmore LC, Kuerer HM, Barcenas CH, Smith BD, Miggins MV, Lucci A, Caudle AS, Meric-Bernstam F, Hunt KK, Teshome M. ASO Visual Abstract: Clinical Course of Breast Cancer Patients with Local Regional Progression During Neoadjuvant Systemic Therapy. Ann Surg Oncol. e-Pub 2021. PMID: 34743278.
Swanick CW, Jiang J, Maldonado JA, Lei X, Shih YT, Caudle AS, Baumann DP, Giordano SH, Shaitelman SF, Shirvani SM, Smith BD. Differences in Time Burden across Local Therapy Strategies for Early-stage Breast Cancer. Plast Reconstr Surg Glob Open 9(11):e3904, 2021. e-Pub 2021. PMID: 34745797.
Simons JM, Scoggins ME, Kuerer HM, Krishnamurthy S, Yang WT, Sahin AA, Shen Y, Lin H, Bedrosian I, Mittendorf EA, Thompson A, Lane DL, Hunt KK, Caudle AS. Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients. Ann Surg Oncol 28(8):4277-4283, 2021. e-Pub 2021. PMID: 33417121.
Elmore LC, Kuerer HM, Barcenas CH, Smith BD, Miggins MV, Lucci A, Caudle AS, Meric-Bernstam F, Hunt KK, Teshome M. Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy. Ann Surg Oncol. e-Pub 2021. PMID: 34247335.
Kothari AN, DiBrito SR, Lee JJ, Caudle AS, Clemens MW, Gottumukkala VN, Katz MHG, Offodile AC, Uppal A, Team D, Chang GJ. Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection. Ann Surg Oncol. e-Pub 2021. PMID: 34176060.
Singareeka Raghavendra A, Alameddine HF, Andersen CR, Selber JC, Brewster AM, Barcenas CH, Caudle AS, Arun BK, Tripathy D, Ibrahim NK. Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer. Cancers (Basel) 13(9), 2021. e-Pub 2021. PMID: 33922702.
Santiago L, Volk RJ, Checka CM, Black D, Lee J, Colen JS, Akay C, Caudle AS, Kuerer H, Arribas EM. Acceptability of 3D-printed breast models and their impact on the decisional conflict of breast cancer patients: A feasibility study. J Surg Oncol 123(5):1206-1214, 2021. e-Pub 2021. PMID: 33577715.
Lim B, Song J, Ibrahim NK, Koenig KB, Chavez-MacGregor M, Ensor JE, Gomez JS, Krishnamurthy S, Caudle AS, Shaitelman SF, Whitman GJ, Valero V. A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2-Negative Breast Cancer. Oncologist 26(2):e230-e240, 2021. e-Pub 2021. PMID: 33140515.
Kothari AN, Trans AT, Caudle AS, Clemens MW, Katz MHG, Woodman SE, Chang GJ. Universal preoperative SARS-CoV-2 testing can facilitate safe surgical treatment during local COVID-19 surges. Br J Surg 108(1):e24-e26, 2021. e-Pub 2021. PMID: 33640925.
Coroneos CJ, Woodward WA, Wong FC, Caudle AS, Shaitelman SF, Kuerer HM, Schaverien MV. Anatomy and physiology of the sentinel lymph nodes of the upper extremity: Implications for axillary reverse mapping in breast cancer. J Surg Oncol. e-Pub 2020. PMID: 33333583.
Singh P, Scoggins ME, Sahin AA, Hwang RF, Kuerer HM, Caudle AS, Mittendorf EA, Thompson AM, Bedrosian I, Teshome M, DeSnyder SM, Meric Caudle AS, Mittendorf EA, Thompson AM, Bedrosian I, Teshome M, DeSnyder SM, Meric-Bernstam F, Hunt KK-Bernstam F, Hunt KK. Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective, Phase IV Trial. Ann Surg Open 1(2), 2020. e-Pub 2020. PMID: 34017965.
Tamirisa N, Lei X, Caudle AS, Giordano SH, Zhao H, Chavez-MacGregor M. Impact of SSO-ASTRO "No Ink on Tumor" Guidelines on Reexcision Rates among Older Breast Cancer Patients. Ann Surg Oncol. e-Pub 2020. PMID: 33225394.
Davis J, Hoskin TL, Day CN, Wickre M, Piltin MA, Caudle AS, Boughey JC. Performance and Clinical Utility of Models Predicting Eradication of Nodal Disease in Patients with Clinically Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy by Tumor Biology. Ann Surg Oncol 27(12):4678-4686, 2020. e-Pub 2020. PMID: 32729046.
Sharabi SE, Baumann DP, Selber JC, Killon E, Mericli AF, Liu J, Caudle AS, Smith BD, Chavez-MacGregor M, Schaverien MV. Complications of Contralateral Prophylactic Mastectomy: Do They Delay Adjuvant Therapy?. Plast Reconstr Surg 146(5):945-953, 2020. e-Pub 2020. PMID: 33136936.
Tzeng CD, Teshome M, Katz MHG, Weinberg JS, Lai SY, Antonoff MB, Bird JE, Shafer A, Davis JW, Adelman DM, Moon B, Reece G, Prabhu SS, DeSnyder SM, Skibber JM, Mehran R, Schmeler K, Roland CL, Tran Cao HS, Aloia TA, Caudle AS, Swisher SG, Vauthey JN. Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg 272(2):e106-e111, 2020. e-Pub 2020. PMID: 32675511.
Schaverien MV, Kuerer HM, Caudle AS, Smith BD, Hwang RF, Robb GL. Outcomes of Volume Replacement Oncoplastic Breast-Conserving Surgery Using Chest Wall Perforator Flaps: Comparison with Volume Displacement Oncoplastic Surgery and Total Breast Reconstruction. Plast Reconstr Surg 146(1):14-27, 2020. e-Pub 2020. PMID: 32590634.
Deigni OA, Baumann DP, Adamson KA, Garvey PB, Selber JC, Caudle AS, Smith BD, Hanson SE, Robb GL, Schaverien MV. Immediate Contralateral Mastopexy/Breast Reduction for Symmetry Can Be Performed Safely in Oncoplastic Breast-Conserving Surgery. Plast Reconstr Surg 145(5):1134-1142, 2020. e-Pub 2020. PMID: 32332525.
Hwang ES, Hyslop T, Hendrix LH, Duong S, Bedrosian I, Price E, Caudle AS, Hieken T, Guenther J, Hudis CA, Winer E, Lyss AP, Dickson-Witmer D, Hoefer R, Ollila DW, Hardman T, Marks J, Chen YY, Krings G, Esserman L, Hylton N. Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance). J Clin Oncol 38(12):1284-1292, 2020. e-Pub 2020. PMID: 32125937.
Marcus RK, Lillemoe HA, Caudle A, Weinberg JS, Gidley PW, Skibber JM, Levenback CF, Swisher SG, Aloia TA. Facilitation of Surgical Innovation: Is It Possible to Speed the Introduction of New Technology While Simultaneously Improving Patient Safety?. Ann Surg 270(6):937-941, 2019. e-Pub 2019. PMID: 30946086.
Weiss A, Lopez NE, Ward EP, Lee KC, Caudle AS, Dickson-Witmer D, Chang C, Kelly K, Martin LW, Jacobs LK, Hunt KK, Yao K, Blair SL. Challenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC). Ann Surg Oncol 26(13):4364-4371, 2019. e-Pub 2019. PMID: 31625045.
Park KU, Kyrish K, Yi M, Bedrosian I, Caudle AS, Kuerer HM, Hunt KK, Miggins MV, DeSnyder SM. Opioid Use after Breast-Conserving Surgery: Prospective Evaluation of Risk Factors for High Opioid Use. Ann Surg Oncol. e-Pub 2019. PMID: 31820211.
Narula N, Lillemoe HA, Caudle A, Chemaly RF, Anderson JJ, Segal C, Porter CA, Swisher SG, Levenback CF, Aloia TA. Postoperative Urinary Tract Infection Quality Assessment and Improvement: The S.T.O.P. UTI Program and Its Impact on Hospitalwide CAUTI Rates. Jt Comm J Qual Patient Saf 45(10):686-693, 2019. e-Pub 2019. PMID: 31371099.
Adamson K, Chavez-MacGregor M, Caudle A, Smith B, Baumann D, Liu J, Schaverien M. Neoadjuvant Chemotherapy does not Increase Complications in Oncoplastic Breast-Conserving Surgery. Ann Surg Oncol 26(9):2730-2737, 2019. e-Pub 2019. PMID: 31037439.
Shin K, Weaver O, Wei W, Caudle A, Kuerer HM, Yang WT. Sonographic features of benign and malignant axillary nodes post-neoadjuvant chemotherapy. Breast J. e-Pub 2019. PMID: 31448480.
Weiss A, Lin H, Babiera GV, Bedrosian I, Shaitelman SF, Shen Y, Kuerer HM, Mittendorf EA, Caudle A, Hunt KK, Hwang RF. Evolution in practice patterns of axillary management following mastectomy in patients with 1-2 positive sentinel nodes. Breast Cancer Res Treat 176(2):435-444, 2019. e-Pub 2019. PMID: 31025270.
Hu Q, Ye Y, Chan LC, Li Y, Liang K, Lin A, Egranov SD, Zhang Y, Xia W, Gong J, Pan Y, Chatterjee SS, Yao J, Evans KW, Nguyen TK, Park PK, Liu J, Coarfa C, Donepudi SR, Putluri V, Putluri N, Sreekumar A, Ambati CR, Hawke DH, Marks JR, Gunaratne PH, Caudle A, Sahin AA, Hortobagyi GN, Meric-Bernstam F, Chen L, Yu D, Hung MC, Curran MA, Han L, Lin C, Yang L. Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression. Nat Immunol 20(7):835-851, 2019. e-Pub 2019. PMID: 31160797.
Park KU, Kyrish K, Terrell J, Yi M, Caudle A, Hunt KK, Kuerer HM, Bedrosian I, Thompson A, DeSnyder SM, Study Group OMODOBSO. Surgeon perception versus reality: Opioid use after breast cancer surgery. J Surg Oncol 119(7):909-915, 2019. e-Pub 2019. PMID: 30737785.
Tevis SE, Bassett R, Bedrosian I, Barcenas CH, Black DM, Caudle A, DeSnyder SM, Fitzsullivan E, Hunt KK, Kuerer HM, Lucci A, Meric-Bernstam F, Mittendorf EA, Park K, Teshome M, Thompson AM, Hwang RF. OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients. Ann Surg Oncol 26(3):815-820, 2019. e-Pub 2019. PMID: 30556120.
Caudle A, Kuerer HM, Krishnamurthy S, Shin K, Hobbs BP, Ma J, Mittendorf EA, Washington AC, DeSnyder SM, Black DM, Hunt KK, Yang WT. Feasibility of fine-needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry study. Cancer 125(3):365-373, 2019. e-Pub 2019. PMID: 30359480.
Stecklein SR, Park M, Liu DD, Valle Goffin JJ, Caudle AS, Mittendorf EA, Barcenas CH, Mougalian S, Woodward WA, Valero V, Sahin AA, Yang WT, Shaitelman SF. Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy. Int J Radiat Oncol Biol Phys 102(3):568-577, 2018. e-Pub 2018. PMID: 29928946.
Tevis SE, Neuman HB, Mittendorf EA, Kuerer HM, Bedrosian I, DeSnyder SM, Thompson AM, Black DM, Scoggins ME, Sahin AA, Hunt KK, Caudle AS. Multidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive Margins. Ann Surg Oncol 25(10):2932-2938, 2018. e-Pub 2018. PMID: 29947001.
Weiss A, Mittendorf EA, DeSnyder SM, Hwang RF, Bea V, Bedrosian I, Hoffman K, Adrade B, Sahin AA, Kuerer HM, Hunt KK, Caudle AS. Expanding Implementation of ACOSOG Z0011 in Surgeon Practice. Clin Breast Cancer 18(4):276-281, 2018. e-Pub 2018. PMID: 29100726.
Van Wyhe RD, Caudle AS, Shaitelman SF, Perkins GH, Buchholz TA, Hoffman KE, Strom EA, Smith BD, Tereffe W, Woodward WA, Stauder MC. A component of lobular carcinoma in clinically lymph node-negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer. Adv Radiat Oncol 3(3):252-257, 2018. e-Pub 2018. PMID: 30197937.
Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Black DM, Santiago L, Hobbs BP, Lucci A, Gilcrease M, Hwang RF, Candelaria RP, Chavez-MacGregor M, Smith BD, Arribas E, Moseley T, Teshome M, Miggins MV, Valero V, Hunt KK, Yang WT. A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Ann Surg 267(5):946-951, 2018. e-Pub 2018. PMID: 28549010.
Caudle AS, Bedrosian I, Milton DR, DeSnyder SM, Kuerer HM, Hunt KK, Mittendorf EA. Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members. Ann Surg Oncol 24(10):2925-2934, 2017. e-Pub 2017. PMID: 28766207.
Tadros AB, Yang WT, Krishnamurthy S, Rauch GM, Smith BD, Valero V, Black DM, Lucci A, Caudle AS, DeSnyder SM, Teshome M, Barcenas CH, Miggins M, Adrada BE, Moseley T, Hwang RF, Hunt KK, Kuerer HM. Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery. JAMA Surg 152(7):665-670, 2017. e-Pub 2017. PMID: 28423171.
Sandberg LJ, Clemens MW, Symmans WF, Valero V, Caudle AS, Smith B, Kuerer HM, Hsu L, Kronowitz SJ. Molecular Profiling Using Breast Cancer Subtype to Plan for Breast Reconstruction. Plast Reconstr Surg 139(3):586e-596e, 2017. e-Pub 2017. PMID: 28234813.
FitzSullivan E, Bassett RL, Kuerer HM, Mittendorf EA, Yi M, Hunt KK, Babiera GV, Caudle AS, Black DM, Bedrosian I, Reyna C, Teshome M, Meric-Bernstam F, Hwang R. Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy. Ann Surg Oncol 24(3):652-659, 2017. e-Pub 2017. PMID: 27822630.
Smith BD, Jiang J, Shih YC, Giordano SH, Huo J, Jagsi R, Momoh AO, Caudle AS, Hunt KK, Shaitelman SF, Buchholz TA, Shirvani SM. Cost and Complications of Local Therapies for Early-Stage Breast Cancer. J Natl Cancer Inst 109(1), 2017. e-Pub 2017. PMID: 27678203.
Shaitelman SF, Stauder MC, Allen P, Reddy S, Lakoski S, Atkinson B, Reddy J, Amaya D, Guerra W, Ueno N, Caudle A, Tereffe W, Woodward WA. Impact of Statin Use on Outcomes in Triple Negative Breast Cancer. J Cancer 8(11):2026-2032, 2017. e-Pub 2017. PMID: 28819403.
Shin K, Caudle AS, Kuerer HM, Santiago L, Candelaria RP, Dogan B, Leung J, Krishnamurthy S, Yang W. Radiologic Mapping for Targeted Axillary Dissection: Needle Biopsy to Excision. AJR Am J Roentgenol 207(6):1372-1379, 2016. e-Pub 2016. PMID: 27726422.
Stauder MC, Caudle AS, Allen PK, Shaitelman SF, Smith BD, Hoffman KE, Buchholz TA, Chavez-Macgregor M, Hunt KK, Meric-Bernstam F, Woodward WA. Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy. Int J Radiat Oncol Biol Phys 96(3):637-44, 2016. e-Pub 2016. PMID: 27681760.
Carter SA, Lyons GR, Kuerer HM, Bassett RL, Oates S, Thompson A, Caudle AS, Mittendorf EA, Bedrosian I, Lucci A, DeSnyder SM, Babiera G, Yi M, Baumann DP, Clemens MW, Garvey PB, Hunt KK, Hwang RF. Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction. Ann Surg Oncol 23(10):3190-8, 2016. e-Pub 2016. PMID: 27406093.
Vila J, Mittendorf EA, Farante G, Bassett RL, Veronesi P, Galimberti V, Peradze N, Stauder MC, Chavez-MacGregor M, Litton JF, Huo L, Kuerer HM, Hunt KK, Caudle AS. Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer. Ann Surg Oncol 23(11):3501-9, 2016. e-Pub 2016. PMID: 27216742.
Shirvani SM, Jiang J, Likhacheva A, Hoffman KE, Shaitelman SF, Caudle A, Buchholz TA, Giordano SH, Smith BD. Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform. Int J Radiat Oncol Biol Phys 95(2):605-16, 2016. e-Pub 2016. PMID: 27034179.
Sanford RA, Lei X, Barcenas CH, Mittendorf EA, Caudle AS, Valero V, Tripathy D, Giordano SH, Chavez-MacGregor M. Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients. Ann Surg Oncol 23(5):1515-21, 2016. e-Pub 2016. PMID: 26678405.
Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, Bedrosian I, Hobbs BP, DeSnyder SM, Hwang RF, Adrada BE, Shaitelman SF, Chavez-MacGregor M, Smith BD, Candelaria RP, Babiera GV, Dogan BE, Santiago L, Hunt KK, Kuerer HM. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. J Clin Oncol 34(10):1072-8, 2016. e-Pub 2016. PMID: 26811528.
Swisher SK, Vila J, Tucker SL, Bedrosian I, Shaitelman SF, Litton JK, Smith BD, Caudle AS, Kuerer HM, Mittendorf EA. Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy. Ann Surg Oncol 23(3):749-56, 2016. e-Pub 2016. PMID: 26511263.
Rauch GM, Hobbs BP, Kuerer HM, Scoggins ME, Benveniste AP, Park YM, Caudle AS, Fox PS, Smith BD, Adrada BE, Krishnamurthy S, Yang WT. Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence. Ann Surg Oncol 23(2):482-9, 2016. e-Pub 2016. PMID: 26416712.
Kim BJ, Caudle AS, Gottumukkala V, Aloia TA. The Impact of Postoperative Complications on a Timely Return to Intended Oncologic Therapy (RIOT): The Role of Enhanced Recovery in the Cancer Journey. Int Anesthesiol Clin 54(4):e33-46, 2016. e-Pub 2016. PMID: 27623128.
Francis AM, Haugen CE, Grimes LM, Crow JR, Yi M, Mittendorf EA, Bedrosian I, Caudle AS, Babiera GV, Krishnamurthy S, Kuerer HM, Hunt KK. Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?. Ann Surg Oncol 22(13):4270-9, 2015. e-Pub 2015. PMID: 25905585.
Shaitelman SF, Tereffe W, Dogan BE, Hess KR, Caudle AS, Valero V, Stauder MC, Krishnamurthy S, Candelaria RP, Strom EA, Woodward WA, Hunt KK, Buchholz TA, Whitman GJ. Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment. Int J Radiat Oncol Biol Phys 93(1):102-10, 2015. e-Pub 2015. PMID: 26279028.
Caudle AS, Yang WT, Mittendorf EA, Black DM, Hwang R, Hobbs B, Hunt KK, Krishnamurthy S, Kuerer HM. Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial. JAMA Surg 150(2):137-43, 2015. e-Pub 2015. PMID: 25517573.
Caudle AS, Kuerer HM, Le-Petross HT, Yang W, Yi M, Bedrosian I, Krishnamurthy S, Fornage BD, Hunt KK, Mittendorf EA. Predicting the extent of nodal disease in early-stage breast cancer. Ann Surg Oncol 21(11):3440-7, 2014. e-Pub 2014. PMID: 24859939.
Xiang DB, Wei B, Abraham SC, Huo L, Albarracin CT, Zhang H, Babiera G, Caudle AS, Akay CL, Rao P, Zhao YJ, Lu X, Wu Y. Molecular cytogenetic characterization of mammary neuroendocrine carcinoma. Hum Pathol 45(9):1951-6, 2014. e-Pub 2014. PMID: 25074542.
Mittendorf EA, Caudle AS, Yang W, Krishnamurthy S, Shaitelman S, Chavez-MacGregor M, Woodward WA, Bedrosian I, Kuerer HM, Hunt KK. Implementation of the american college of surgeons oncology group z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?. Ann Surg Oncol 21(8):2468-73, 2014. e-Pub 2014. PMID: 24841348.
Haynes AB, Bloom ES, Bedrosian I, Kuerer HM, Hwang RF, Munsell MF, Chemaly RF, Graviss LS, Caudle AS, Hunt KK, Tereffe W, Shaitelman SF, Babiera GV. Timing of infectious complications following breast-conserving therapy with catheter-based accelerated partial breast irradiation. Ann Surg Oncol 21(8):2512-6, 2014. e-Pub 2014. PMID: 24736987.
MacDermond DM, Houtman KM, Thang SH, Allen PK, Caudle AS, Gainer SM, Hunt KK, Perkins GH, Shaitelman SF, Smith BD, Strom EA, Tereffe W, Woodward WA, Buchholz TA, Hoffman KE. Therapeutic radiation dose delivered to the low axilla during whole breast radiation therapy in the prone position: Implications for targeting the undissected axilla. Pract Radiat Oncol 4(2):116-22, 2014. e-Pub 2014. PMID: 24890352.
Caudle AS, Yi M, Hoffman KE, Mittendorf EA, Babiera GV, Hwang RF, Meric-Bernstam F, Sahin AA, Hunt KK. Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients. Ann Surg Oncol 21(1):60-5, 2014. e-Pub 2014. PMID: 24046126.
Wang J, Mittendorf EA, Sahin AA, Min Y, Caudle AS, Hunt KK, Wu Y. Outcomes of sentinel lymph node dissection alone verses axillary lymph node dissection in early stage invasive lobular carcinoma: A retrospective study of the Surveillance, Epidemiology, and End Results (SEER) Database. PLoS One 9(2):e89778, 2014. e-Pub 2014. PMID: 24587029.
Fitzsullivan E, Lari SA, Smith B, Caudle AS, Krishnamurthy S, Lucci A, Mittendorf EA, Babiera GV, Black DM, Wagner JL, Bedrosian I, Woodward W, Gainer SM, Hwang R, Meric-Bernstam F, Hunt KK, Kuerer HM. Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?. Ann Surg Oncol 20(13):4103-12, 2013. e-Pub 2013. PMID: 23975313.
Yi M, Kuerer HM, Mittendorf EA, Hwang RF, Caudle AS, Bedrosian I, Meric-Bernstam F, Wagner JL, Hunt KK. Impact of the American College of Surgeons Oncology Group Z0011 criteria applied to a contemporary patient population. J Am Coll Surg 216(1):105-13, 2013. e-Pub 2013. PMID: 23122536.
Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, Arun BK, Lucci A, Babiera GV, Wagner JL, Caudle AS, Meric-Bernstam F, Hwang RF, Bedrosian I, Hunt KK, Kuerer HM. Biology, Treatment, and Outcome in Very Young and Older Women with DCIS. Ann Surg Oncol 19(12):3777-84, 2012. e-Pub 2012. PMID: 22622473.
Alvarado R, Yi M, Le-Petross H, Gilcrease M, Mittendorf EA, Bedrosian I, Hwang RF, Caudle AS, Babiera GV, Akins JS, Kuerer HM, Hunt KK. The role for sentinel lymph node biopsy after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. Ann Surg Oncol 19(10):3177-84, 2012. e-Pub 2012. PMID: 22772869.
Caudle AS, Hunt KK, Tucker SL, Hoffman K, Gainer SM, Lucci A, Kuerer HM, Meric-Bernstam F, Shah R, Babiera GV, Sahin AA, Mittendorf EA. American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on surgeon practice patterns. Ann Surg Oncol 19(10):3144-51, 2012. e-Pub 2012. PMID: 22847123.
Gainer SM, Hunt KK, Beitsch P, Caudle AS, Mittendorf EA, Lucci A. Changing behavior in clinical practice in response to the ACOSOG Z0011 Trial: A survey of the American Society of Breast Surgeons. Ann Surg Oncol 19(10):3152-8, 2012. e-Pub 2012. PMID: 22820938.
Kuerer HM, Lari SA, Arun BK, Hu CY, Brewster A, Mittendorf EA, Albarracin CT, Babiera GV, Caudle AS, Wagner JL, Litton JK, Bedrosian I, Meric-Bernstam F, Lucci A, Hunt KK. Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass. Breast Cancer Res Treat 133(3):1131-41, 2012. e-Pub 2012. PMID: 22392043.
Caudle AS, Yu TK, Tucker SL, Bedrosian I, Litton JK, Gonzalez-Angulo AM, Hoffman K, Meric-Bernstam F, Hunt KK, Buchholz TA, Mittendorf EA. Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy. Breast Cancer Res 14(3):R83, 2012. e-Pub 2012. PMID: 22621334.
Caudle AS, Hunt KK, Kuerer HM, Meric-Bernstam F, Lucci A, Bedrosian I, Babiera GV, Hwang RF, Ross MI, Feig BW, Hoffman K, Litton JK, Sahin AA, Yang W, Hortobagyi GN, Buchholz TA, Mittendorf EA. Multidisciplinary considerations in the implementation of the findings from the american college of surgeons oncology group (ACOSOG) Z0011 Study: A Practice-Changing Trial. Ann Surg Oncol 18(9):2407-12, 2011. e-Pub 2011. PMID: 21327455.
Caudle AS, Gonzalez-Angulo AM, Hunt KK, Pusztai L, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancer. Ann Surg Oncol 18(4):932-8, 2011. e-Pub 2011. PMID: 21061075.
Poindexter NJ, Williams RR, Powis G, Jen E, Caudle AS, Chada S, Grimm EA. IL-24 is expressed during wound repair and inhibits TGFalpha-induced migration and proliferation of keratinocytes. Exp Dermatol 19(8):714-22, 2010. e-Pub 2010. PMID: 20545760.
Caudle AS, Gonzalez-Angulo AM, Hunt KK, Liu P, Pusztai L, Symmans WF, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer. J Clin Oncol 28(11):1821-8, 2010. e-Pub 2010. PMID: 20231683.
Beasley GM, Caudle AS, Petersen RP, McMahon NS, Padussis J, Mosca PJ, Zager JS, Hochwald SN, Grobmyer SR, Delman KA, Andtbacka RH, Noyes RD, Kane JM, Seigler H, Pruitt SK, Ross MI, Tyler DS. A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US. J Am Coll Surg 208(5):706-15; discussion 715-7, 2009. e-Pub 2009. PMID: 19476821.
Caudle AS, Kim HJ, Tepper JE, O'Neil BH, Lange LA, Goldberg RM, Bernard SA, Calvo BF, Meyers MO. Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer. Ann Surg Oncol 15(7):1931-6, 2008. e-Pub 2008. PMID: 18418656.
Caudle AS, Tepper JE, Calvo BF, Meyers MO, Goyal LK, Cance WG, Kim HJ. Complications associated with neoadjuvant radiotherapy in the multidisciplinary treatment of retroperitoneal sarcomas. Ann Surg Oncol 14(2):577-82, 2007. e-Pub 2007. PMID: 17119868.
Caudle AS, Brier SE, Calvo BF, Kim HJ, Meyers MO, Ollila DW. Experienced radio-guided surgery teams can successfully perform minimally invasive radio-guided parathyroidectomy without intraoperative parathyroid hormone assays. Am Surg 72(9):785-9; discussion 790, 2006. e-Pub 2006. PMID: 16986387.
Ollila DW, Caudle AS, Cance WG, Kim HJ, Cusack JC, Swasey JE, Calvo BF. Successful minimally invasive parathyroidectomy for primary hyperparathyroidism without using intraoperative parathyroid hormone assays. Am J Surg 191(1):52-6, 2006. e-Pub 2006. PMID: 16399106.

Invited Articles

Racz JM, Caudle A. Sentinel Node Lymph Node Surgery After Neoadjuvant Therapy: Principles and Techniques. Ann Surg Oncol. e-Pub 2019. PMID: 31342394.
Caudle AS, Smith BD. Do Internal Mammary Nodes Matter?. Ann Surg Oncol 26(4):930-932, 2019. e-Pub 2019. PMID: 30617872.
Caudle AS. Intraoperative Pathologic Evaluation with Targeted Axillary Dissection : Editorial for "Intraoperative Touch Imprint Cytology in Targeted Axillary Dissection After Neoadjuvant Chemotherapy Among Breast Cancer Patients with Initial Axillary Metastasis". Ann Surg Oncol 25(11):3112-3114, 2018. e-Pub 2018. PMID: 30054821.
Park KU, Caudle A. Management of the Axilla in the Patient with Breast Cancer. Surg Clin North Am 98(4):747-760, 2018. e-Pub 2018. PMID: 30005771.
Kim BJ, Caudle AS, Gottumukkala V, Aloia TA. The Impact of Postoperative Complications on a Timely Return to Intended Oncologic Therapy (RIOT): The Role of Enhanced Recovery in the Cancer Journey. Int Anesthesiol Clin 54(4), 2016. e-Pub 2016. PMID: 27623128.
Caudle AS, Kuerer HM. Targeting and limiting surgery for patients with node-positive breast cancer. BMC-Medicine 13(1):149, 2015. e-Pub 2015. PMID: 26109042.
Caudle AS, Thompson AM. Less Remains Better: Morbidity After Axillary Surgery. Ann Surg Oncol 22(1):4-6, 2015. e-Pub 2015. PMID: 25047480.
Caudle AS, Kuerer HM. Breast Conservation Therapy After Neoadjuvant Chemotherapy: Optimization of a Multimodality Approach. J Surg Oncol 110(1):32-6, 2014. e-Pub 2014. PMID: 24623334.
Caudle AS, Cupp JA, Kuerer HM. Management of Axillary Disease. Surg Oncol Clin N Am 23(3):473-486, 2014. e-Pub 2014. PMID: 24882346.
Caudle AS. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients with Cytologically Proven Node-Positive Breast Cancer at Diagnosis. Breast Diseases: A Year Book Quarterly 25(3), 2014. e-Pub 2014.
Caudle AS. Commentary on: Breast-Conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer. Breast Diseases: A Year Book Quarterly 25(1), 2014. e-Pub 2014.
Caudle AS, Tereffe W, Mittendorf EA. Should local therapy of invasive breast cancer be tailored based on subtype?. Current Breast Cancer Reports. e-Pub 2013.
Caudle AS. Cancer Management Question Development. American Board of Medical Specialties Maintenance of Certification: Breast Education and Self-Assessment Program, 2013. e-Pub 2013.
Caudle AS. Is Nipple-Sparing Mastectomy a Safe Oncologic Procedure?. Breast Diseases:A Year Book Quarterly 23(3), 2013. e-Pub 2013.
Caudle AS. Commentary on: Rare breast cancer: 933 adenoid cystic carcinomas from the national cancer data base. Breast Diseases: A Year Book Quarterly 24(4), 2013. e-Pub 2013.
Caudle AS. Is there a role for sentinel lymph node dissection in patients with ductal carcinoma in situ?. Breast Diseases: A Year Book Quarterly 23(1), 2012. e-Pub 2012.
Caudle AS, Kuerer HM. Large national cooperative group trial examines survival endpoint associated with breast cancer occult metastases. J Watch Oncol and Hematol, 2012. e-Pub 2012.
Caudle AS. Does blue dye contribute to success of sentinel node mapping for breast cancer. Breast Diseases:A Year Book Quarterly 22(3), 2011. e-Pub 2011.
Caudle AS, Hunt KK. The neoadjuvant approach in breast cancer treatment: it is not just about chemotherapy anymore. Curr Opin Obstet Gynecol 23(1):31-6, 2011. e-Pub 2011. PMID: 21124221.
Caudle AS, Ross MI. Metastasectomy for Stage IV Melanoma: For Whom and How Much?. Surg Oncol Clin N Am 20(1):133-44, 2011. e-Pub 2011. PMID: 21111963.
Ollila DW, Caudle AS. Surgical management of distant metastases. Surg Oncol Clin N Am 15(2):385-98, 2006. e-Pub 2006. PMID: 16632222.

Manuals, Teaching Aids, Other Teaching Publications

Caudle AS. Cancer Management Question Development; American Board of Medical Specialties Maintenance of Certification: Breast Education and Self-Assessment Program, 2013.
Caudle AS, Haas E, Walkup M, Kim HJ. Surgery Section. Appleton & Lange, 2005.

Abstracts

Alameddine HF, Singareeka A, Anderson C, Selber JC, Brewster A, Barcenas CH, Caudle AS, Arun B, Ibrahim N. Decision making process and contralateral prophylactic mastectomy, 2020. e-Pub 2020.
Min Y, Chavez-MacGregor M, Smith BD, Caudle AS, DeSnyder SM, Kuerer HM, Hunt KK. Comparing survival differences between breast-conserving therapy and mastectomy in patients with early-stage breast cancer undergoing upfront surgery. AACR San Antonio Breast Cancer Symposium Abstract PS1-17, 2020. e-Pub 2020.
Min Y, Chavez-MacGregor M, Smith BD, Caudle AS, DeSnyder SM, Kuerer HM, Hunt KK. Comparing survival differences between breast-conserving therapy and mastectomy in patients with early-stage breast cancer undergoing upfront surgery, 2020. e-Pub 2020.
Alameddine HF, Singareeka A, Anderson C, Selber JC, Brewster A, Barcenas CH, Caudle AS, Arun B, Ibrahim N. Decision making process and contralateral prophylactic mastectomy. AACR San Antion Breast Cancer Symposium Abstract PS9-13, 2020. e-Pub 2020.
Ma CX, Suman V, Leitch AM, Sanati S, Vij K, Unzeitig GW, Hoog J, Watson M, Hahn O, Guenther J, Caudle AS, Crouch E, Maluf H, Tierstan A, Mita M, Razaq W, Hieken TJ, Wang Y, Dockter T, Zujewski J, Weiss A, Hunt KK, Hudis C, Winer EP, Ellis MJ, Carey LA, Partridge AH. Neoadjuvant chemotherapy response in postmenopausal women with clinical stage II or III estrogen receptor positive (ER+) and HER2 negative (HER2-) breast cancer resistant to endocrine therapy in the ALTERNATE trial (Alliance A011106). AACR San Antonio Breast Symposium Abstract GS4-01, 2020. e-Pub 2020.
Ma CX, Suman V, Leitch AM, Sanati S, Vij K, Unzeitig GW, Hoog J, Watson M, Hahn O, Guenther J, Caudle AS, Crouch E, Maluf H, Tierstan A, Mita M, Razaq W, Hieken TJ, Wang Y, Dockter T, Zujewski J, Weiss A, Hunt KK, Hudis C, Winer EP, Ellis MJ, Carey LA, Partridge AH. Neoadjuvant chemotherapy response in postmenopausal women with clinical stage II or III estrogen receptor positive (ER+) and HER2 negative (HER2-) breast cancer resistant to endocrine therapy in the ALTERNATE trial (Alliance A011106, 2020. e-Pub 2020.
Kimmick G, Dueck AC, Shelby R, Naughton M, Caudle AS, Fruth B, Hwang ES. Musculoseletal side effects over time and association with adherence in women taking neoadjuvant letrozole for estrtogen positive DCIS: CALGB 40903 (Alliance), 2019. e-Pub 2019.
Kimmick G, Dueck AC, Shelby R, Naughton M, Caudle AS, Fruth B, Hwang ES. Musculoseletal side effects over time and association with adherence in women taking neoadjuvant letrozole for estrtogen positive DCIS: CALGB 40903 (Alliance). AACR San Antonio Breast Cancer Symposium Abstract P5-14-17, 2019. e-Pub 2019.
Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Bedrosian I, Hunt K, Kuerer HM. Factors impacting the accuracy of targeted axillary dissection. Ann Surg Oncol 24 (Suppl 1): Abstract 14, 2017. e-Pub 2017.
Tadros A, Yang WT, Krishnamurthy S, Rauch G, Smith B, Valero V, Black DM, Caudle AS, Lucci A, DeSnyder S, Teshome M, Barcenas C, Miggins M, Moseley T, Adrada B, Hwang R, Hunt KK, Kuerer HM. Eliminating axillary surgery in exceptional responders to neoadjuvant chemotherapy with documented pathologic complete response in the breast. Ann Surg Oncol 24 (Suppl 1): Abstract 15, 2017. e-Pub 2017.
Hwang ES, Duong S, Bedrosian I, Allred J, Wisner D, Hyslop T, Caudle AS, Hieken T, Guenther J, Esserman L, Hylton N. Primary Endocrine Therapy for Ductal Carcinoma in Situ (DCIS) CALGB 40903 (alliance). AACR San Antonio Breast Conference, 2017, 2017. e-Pub 2017.
Caudle AS, Bedrosian I, Milton DR, DeSnyder SM, Kuerer HM, Hunt KK, Mittendorf EA. The use of sentinel lymph node dissection after neoadjuvant chemotherapy in clinically node positive patients: Practice patterns of members of the American Society of Breast Surgeons. American Society of Breast Surgeons 2017 Annual Meeting Official Proceedings Abstract 257239 (Volume XVII):28, 2017. e-Pub 2017.
Weiss A, Kuerer HM, Yang WT, Krishnamurthy S, DeSnyder SM, Black DM, Babiera GV, Teshome T, Hunt KK, Caudle AS. Potential for targeted axillary dissection in patients who do not receive neoadjuvant chemotherapy. American Society of Breast Surgeons 2017 Annual Meeting Official Proceedings Abstract 257320 (Volume XVII):163, 2017. e-Pub 2017.
Weiss A, Mittendorf EA, DeSnyder SM, Hwang R, Bedrosian I, Hoffman K, Adrada BE, Bea V, Sahin AA, Kuerer HM, Hunt KK, Caudle AS. ACOSOG Z0011: Impact after 5 years. American Society of Breast Surgeons 2017 Annual Meeting Official Proceedings Abstract 256764 (Volume XVII):168, 2017. e-Pub 2017.
Ross MI, Bedrosian I, Black BM, Mittendorf EA, Caudle AS, Babiera GV, Hwang R, Meric-Bernstam F, Grisson CB, Brulotte M, Andtbacka RHI. A Phase I clinical trial of VST-1001 (dilute fluorescein) in lymphatic mapping and sentinel lymph node localization in clinically node negative breast cancer. Cancer Res 76 (Supp 4) P3-01-09, 2016. e-Pub 2016.
Yi M, Mittendorf EA, Bedrosian I, Black DM, Kuerer HM, DeSnyder SM, Caudle AS, Babiera GV, Hunt KK. Sentinel lymph node dissection in patients with multicentric invasive breast cancer. Ann Surg Onc 20 (Suppl 1): P60, 2016. e-Pub 2016.
Shaitelman S, Stauder M, Allen P, Reddy S, Lakoski S, Atkinson B, Moulder S, Reddy J, Amaya D, Guerra W, Ueno N, Caudle AS, Tereffe W, Woodward W. Impact of Statin use on outcomes in triple negative breast cancer. Int J Radiat Oncol Biol Phys 96(2S), 2016. e-Pub 2016. PMID: 27674802.
Alvarez RH, Koenig KB, Ensor J, Ibrahim NK, Chavez MacGregor M, Litton JK, Schwartz Gomez J, Cyriac A, Krishnamurthy S, Caudle AS, Shaitelman SF, Whitman GJ, Murray JL, Booser DJ, Reuben JM, Valero V. A randomized phase II neoadjuvant study of sequential eribulin followed by FAC/FEC-regimen compared to sequential paclitaxel followed by FAC/FEC-regimen in patients with operable breast cancer not expressing HER2. Cancer Res 76 (Suppl 4) P1-14-04, 2016. e-Pub 2016.
Smith BD, Jiang J, Shih YT, Giordano SH, Jagsi R, Caudle AS, Hunt KK, Buchholz TA, Shirvani SM. Complication and cost burden of local therapy options for early breast cancer. Cancer Res 76 (Suppl 4) S3-07, 2016. e-Pub 2016.
Caudle AS, Fleming J, Garcia BM, Lozano M, Rigby D, Manuel-Byrd R, McMillian L, Avalos C, Hodge R, Butler C, Hunt KK, Baumann BP. Optimizing surgical instrument sets for cases involving breast and plastic surgeons. J Clin Oncol 34 (Suppl 7S): Abstract 33, 2016. e-Pub 2016.
Carter SA, Lyons GR, Bassett RL, Babiera GV, Bedrosian I, Hunt KK, DeSnyder SM, Kuerer HM, Caudle AS, Black D, Ross MI, Teshome M, Thompson A, Yi M, Oates S, Garvey PB, Baumann DP, Hwang R. An Analysis of 5651 surgeries for patients with breast cancer: The emerging trend for breast conservation and oncoplastic reconstruction with oncologic and post-operative outcomes. American Society of Breast Surgeons 2016 Annual Meeting 2016, Official Proceedings 2016 16: 0232, 2016. e-Pub 2016.
Vila J, Mittendorf EA, Bassett RL, Bedrosian I, Shaitelman SF, Stauder MC, Chavez MacGregor M, Litton J, Yang WT, Huo L, Kuerer HM, Hunt KK, Caudle AS. A nomogram to predict axillary response to neoadjuvant chemotherapy in clinically node positive breast patients. J Clin Oncol 22 (Suppl 1) Abstract 1034, 2015. e-Pub 2015.
Sanford RA, Barcenas CH, Caudle AS, Giordano SH, Lei X, Mittendorf EA, Tripathy D, Vicente V, Chaves MacGregor M. Impact of neoadjuvant chemotherapy to surgery interval; on survival outcomes in breast cancer patients. J Clin Oncol 22 (Suppl 1) Abstract 1063, 2015. e-Pub 2015.
Sauder CAM, Stauder M, Hunt KK, Lucci A, Mittendorf EA, Whitman GJ, Kuerer HM, Caudle AS. Outcomes with contralateral axillary nodal metastases in breast cancer. Ann Surg Oncol 22 (Suppl 1) Abstract P63, 2015. e-Pub 2015.
Caudle AS, Yang WT, Mittendorf EA, Black DM, Gilcrease M, Bedrosian I, Hobbs BP, Canderlaria RP, Babiera GV, Dogan BE, Lim MJ, Santiago L, Hunt KK, Krishnamurthy S, Kuerer HM. Targeted axillary dissection improves axillary evaluation following neoadjuvant chemotherapy in node positive patients. Ann Surg Oncol 22 (Suppl 1) Abstract S2, 2015. e-Pub 2015.
Black DM, Wagner J, Mittendorf EA, Hwang RF, DeSnyder SM, Yang WT, Rohren E, Kuerer HM, Hunt KK, Caudle AS. Implementing a radioactive see localization program in breast cancer surgery: A multidisciplinary approach. Ann Surg Oncol 22 (Suppl 1) Abstract P97, 2015. e-Pub 2015.
Goravanchi F, Rigby D, Rebello E, Lange G, Kowalski A, Spencer K, Lucci A, Caudle AS, Baumann D, French K, Kuerer H. Outpatient breast surgery is safe: Recent experience with 10836 patients at M.D. Anderson Cancer Center. 49th International Congress of European Society for Surgical Research (ESSR), 2014. e-Pub 2014.
Boland G, Caudle AS, Prieto V, Curry JL, Cormier JN, Royal RE, Lee JE, Werneke CL, Ross MI, Gershenwald J. Predictors of survival in contemporary era patients with thin melanoma who underwent sentinel node biopsy. Ann Surg Oncol 21 (Suppl 1: S23) Abstract 53, 2014. e-Pub 2014.
Caudle AS, Yang W, Mittendorf EA, Black DM, Gilcrease M, Bedrosian I, Hobbs BP, Canderlaria RP, Babiera GV, Dogan BE, Santiago L, Hunt KK, Krishnamurthy S, Kuerer HM. Improved axillary evaluation following neoadjuvant chemotherapy for node positive patients with image-guided surgery. J Clin Oncol 32 (Suppl 26) Abstract 99, 2014. e-Pub 2014.
Francis AM, Grimes LM, Yi M, Mittendorf EA, Bedrosian I, Caudle AS, Meric-Bernstam F, Babiera GV, Krishnamurthy S, Kuerer HM, Hunt KK. Utility of sentinel lymph node dissection (SLND) in ductal carcinoma in situ (DCIS). Ann Surg Oncol 20 (S1) Abstract P46, 2013. e-Pub 2013.
Caudle AS, Kuerer HM, Le-Petross HT, Yang W, Bedrosian I, Krishnamurthy S, Lucci A, Hunt KK, Mittendorf EA. Predicting the extent of nodal disease in early breast cancer. J Clin Oncol 31 (Suppl 26) Abstract 95, 2013. e-Pub 2013.
Wang J, Mittendorf EA, Sahin AA, Yi M, Caudle AS, Hunt KK, Wu W. Applicability of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial results in invasive lobular carcinoma. J Clin Oncol 31 (Suppl) Abstract 1103, 2013. e-Pub 2013.
FitzSullivan E, Lari SA, Smith B, Caudle AS, Krishnamurthy S, Lucci A, Mittendorf EA, Babiera GV, Black S, Wagner JL, Bedrosian I, Woodward W, Gainer SM, Hwang RF, Meric-Bernstam F, Hunt KK, Kuerer HM. Incidence and consequence of close margins for ductal carcinoma in situ treated with mastectomy. Ann Surg Oncol 20 (S1) Abstract 11, 2013. e-Pub 2013.
FitzSullivan E, Ross MI, Meric-Bernstam F, DeSnyder SM, Bedrosian I, Black S, Lucci A, Caudle AS, Babiera GV, Mittendorf EA, Hunt KK, Yi M, Kuerer HM, Bassett TL, Hwang RF. Outcomes of sentinel lymph node positive breast cancer patients treated with mastectomy without treatment of the axilla: an Institutional and SEER based analysis. J Clin Oncol 31 (Suppl 26) Abstract 53, 2013. e-Pub 2013.
Le-Petross H, Caudle AS, Lari SA, Yang WT, Hunt KK, Alvarez RH, Krishnamurthy S, Kuerer HM. Nodal ultrasound reliability varies with molecular subtypes in breast cancer after neoadjuvant chemotherapy. American Roentgen Ray Society Annual Meeting Proceedings Abstract 1939, 2013. e-Pub 2013.
Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, Arun BK, Lucci A, Babiera GV, Wagner JL, Caudle AS, Meric-Bernstam F, Hwang RF, Bedrosian I, Hunt KK, Kuerer HM. Biology, Treatment, and Outcome in Very Young and Older Women with DCIS. Ann Surg Oncol 17 (Suppl 1)(s58):46. e-Pub 2012. PMID: 22622473.
Gainer SM, Hunt KK, Beitsch P, Caudle AS, Mittendorf EA, Lucci A. Changing behavior in clinical practice in response to the ACOSOG Z0011 Trial: A survey of the American Society of Breast Surgeons. Ann Surg Oncol Abstract 0072, 2012. e-Pub 2012. PMID: 22820938.
Haynes AB, Bloom ES, Bedrosian I, Kuerer HM, Hwang RF, Caudle AS, Hunt KK, Tereffe W, Shaitelman SF, Babiera GV. Timing of infectious complications following breast conserving therapy with catheter-based accelerated partial breast irradiation. Cancer Research 72(24): 409s Abstract P4-15-02, 2012. e-Pub 2012.
Caudle AS, Hunt KK, Tucker SL, Hoffman K, Gainer SM, Lucci A, Kuerer HM, Meric-Bernstam F, Shah R, Babiera GV, Sahin AA, Mittendorf EA. American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on surgeon practice patterns. American Society of Breast Surgeons Official Proceedings Abstract 168, 2012. e-Pub 2012.
Dallas NA, Yi M, Hunt KK, Shah R, Kuerer HM, Litton JK, Wu Y, Caudle AS, Meric-Bernstam F, Sahin AA, Mittendorf EA. Evaluation of the stage IB designation of the 7th Edition of the AJCC Staging System: Receptor status and nuclear grade are better survival discriminants than presence of micrometastases. J Clin Oncol 30(Suppl), 2012. e-Pub 2012.
Alvarado R, Yi M, Le-Petross H, Gilcrease M, Mittendorf EA, Bedrosian I, Hwang RF, Caudle AS, Babiera GV, Akins JS, Kuerer HM, Hunt KK. The role for sentinel lymph node biopsy after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. American Society of Breast Surgeons Official Proceedings, 2012. e-Pub 2012. PMID: 22772869.
Caudle AS, Min Y, Mittendorf EA, Babiera GV, Hwang RF, Meric-Bernstam F, Sahin. The identification of internal mammary sentinel lymph node metastasis impacts therapy in breast cancer. American Society of Breast Surgeons Official Proceedings Abstract 0072, 2012. e-Pub 2012.
Smith MB, Caudle AS, Caskey LS, Meyers MO, Moore DT, Calvo BF. Epiregulin mRNA expression in colorectal hepatic metastases is associated with survival post partial hepatectomy. Ann Surg Oncol 17(Suppl 1):S24, 2010. e-Pub 2010.
Caudle AS, Ross MI, Prieto VG, Warneke CL, Lee JE, Johnson MM, Gardner JL, Royal RE, Cormier JN, Lucci A, Gershenwald JE. Mitotic rate predicts sentinel node involvement in melanoma: Impact of the 7th edition AJCC melanoma staging system. Ann Surg Oncol 17(Suppl 1):S8, 2010. e-Pub 2010.
Caudle AS, Gonzalez-Angulo A, Hunt KK, Ping L, Pusztai L, Symman F, Kuerer H, Mittendorf EA, Hortobagyi G, Meric-Bernstam F. Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer. J Clin Oncol 27:15s, 2009. e-Pub 2009.
Caudle AS, Gonzalez-Angulo AM, Hunt KK, Pusztai L, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Impact of Progression during Neoadjuvant Chemotherapy on Operative Management of Breast Cancer. Cancer Research 69(24):567s, 2009. e-Pub 2009.
Caudle AS, Poindexter N, Grimm EA. Differential regulation of EGFR by IL-24 in human melanoma cells and melanocytes. Proc 100th Ann Mtg of AACR, 2009. e-Pub 2009.
Yeh JJ, Caudle AS, McPhail L, Sigel CS, Caskey L, Routh ED, Kim HJ, Meyers MO, Calvo BF. A molecular signature of clinical risk in patients with colorectal liver metastasis. Ann Surg Oncol 16(S1):S17, 2009. e-Pub 2009.
Sommer CA, Calvo BF, Caudle AS, Yeh JJ, Frank JS, Ollila DW. Multiple strategies to ensure a successful minimally invasive parathyroidectomy. Ann Surg Oncol 16(Suppl 2):51, 2009. e-Pub 2009.
Caudle AS, Willborn K, Abdalla EK, Evans DB, Vauthey JN, Ellis LM, Yao JC. Feasibility of synchronous resection of primary and metastatic. Ann Surg Oncol 15(S2):51, 2008. e-Pub 2008.
Caudle AS, Rubinas TC, Caskey LS, Earp HS, Calvo BF. Measuring the epidermal growth factor receptor and its ligands in paraffin-embedded archived patient samples. ASCO GI Symposium;Orlando, FL, 2007. e-Pub 2007.
Caudle AS, Caskey LS, Earp HS, Calvo BF. Increased amphiregulin and epiregulin expression in colorectal tumors may explain clinical response to EGFR-targeted antibody therapy. Ann Surg Oncol 14(Suppl 2), 2007. e-Pub 2007.
Caudle AS, Calvo BF, Kim HJ, Bernard S, Tepper JE, O’Neil BH, Meyers MO. Diabetes decreases response to neoadjuvant therapy in rectal cancer. Ann Surg Oncol 13(S1), 2006. e-Pub 2006.
Caudle AS, Caskey LS, Earp HS, Calvo BF. Colorectal adenocarcinomas have increased EGFR ligand expression. J Am Coll Surg 203(3):S87, 2006. e-Pub 2006.
Caudle AS, Calvo BF, Meyers MO, Cance WG, Goyal LK, Tepper JE, Kim HJ. Preoperative radiotherapy in the multidisciplinary treatment of retroperitoneal sarcomas. Ann Surg Oncol 12(Suppl), 2005. e-Pub 2005.
Ollila DW, Caudle AS, Cance WG, Kim HJ, Cusack JC, Swasey JE, Calvo BF. Successful minimally invasive parathyroidectomy without intra-operative parathyroid hormone assay. Ann Surg Oncol 11(Suppl 2):S119, 2004. e-Pub 2004.
Tevis S, Bassett R, Bedrosian I, Black DM, Caudle AS, DeSnyder S, FitzSullivan E, Hunt KK, Kuerer HM, Lucci A, MericBernstam F, Mittendorf EA, Park C, Teshome M, Thompson A, Hwang R. Evaluation of OncotypeDX as a Predictor of Nodal Burden in Clincially Node Negative Breast Cancer Patients. American Society of Breast Surgeons Annual Meeting.
Tevis SE, Neuman HB, Mittednorf EA, Kuerer HM, Bedrosian I, Caudle AS DeSnyder SM, Scoggins ME, Sahin AA, Hunt KK. Multidisciplinary Margin Assessment Reduces Number of Positive Margins. American Society of Breast Surgeons Annual Meeting (Accepted for Quickshot Presentation).
DeSnyder SM, Hunt KK, Caudle AS, Buzdar AU, Kuerer HM. Long-term outcome of node positive breast cancer patients treated with neoadjuvant chemotherapy followed by sentinel lymph node biopsy alone. Society of Surgical Oncology Annual Meeting.

Book Chapters

Le-Petross HT, Caudle AS. Breast Cancer Screening and Diagnosis. In: Staging of Breast Cancer. Shetty MK, ed. Springer, 2015.
Caudle AS, Babiera GV. Surgical Management of Disseminated Breast Cancer. In: Advanced Therapy of Breast Disease. 3rd. People’s Publishing House, 2012.
Caudle AS, Delman KA, Cormier JN. Sarcoma: Soft Tissue Sarcoma, Bone Sarcoma. In: The M.D. Anderson Surgical Oncology Handbook,. 5th. Lippincott Williams, & Wilkins, 2012.
Caudle AS, Babiera GV. Management of Recurrent and Disseminated Breast Cancer. In: Cameron’s Current Surgical Therapy. 10th. Elsevier, 952-956, 2011.
Caudle AS, Mittendorf EA, Kuerer HM. Lymphatic Mapping and Sentinel Lymphatic Mapping and Sentinel Lymph Node Biopsy. In: Elective General Surgery: An Evidence-Based Approach. People's Medical Publishing House, 2011.
Caudle AS, Ollila DW. Surgical Resection of Distant Metastases: Rationale, Indications, and Results. In: Advanced Therapy in Surgical Oncology. BC Decker Hamilton, 2008.
Caudle AS, Kim HJ, Tepper JE. Evidence-based Practice: The Role of Adjuvant Radiotherapy in the Treatment of Gastric Adenocarcinoma. In: Gastrointestinal Oncology: Evidence and Analysis. Marcel Dekker, 2005.
Caudle AS, Haas E, Walkup M, and Kim HJ. Surgery. In: USMLE Review, Step 3. 4th Edition. Appleton & Lange, 2005.

Letters to the Editor

Caudle AS, Hunt KK, Mittendorf EA. Response to the Letter to the Editor: Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A practice-changing trial. Ann Surg Oncol 18 Suppl 3: 283, 2011.
Caudle AS, Gonzalez-Angulo AM, Meric-Bernstam F. Response to Letter to the Editor: Strategy for non-responder breast cancer patients to neoadjuvant treatment. Ann Surg Oncol 18 Suppl 3: 288-9, 2011.

Less

Selected Presentations & Talks

Local Presentations

2019. Targeted Axillary Dissection and the Surgical Management of the Axilla after Neoadjuvant Therapy. Conference. Targeted Axillary Dissection and the Surgical Management of the Axilla after Neoadjuvant Therapy. Houston, TX, US.
2019. Targeted Axillary Dissection. Conference. Targeted Axillary Dissection. Houston, TX, US.
2018. Targeted Axillary Dissection in Node (+) Breast Cancer, Invited Speaker. Conference. Targeted Axillary Dissection in Node (+) Breast Cancer, Invited Speaker. Houston, TX, US.
2018. Axillary Management in ER+ Breast Cancer, Invited Speaker. Conference. Axillary Management in ER+ Breast Cancer, Invited Speaker. Houston, TX, US.
2018. Great Debates: All Patients with DCIS Require Surgery, Invited Speaker. Conference. Great Debates: All Patients with DCIS Require Surgery, Invited Speaker. Houston, TX, US.
2017. New Advances in Breast Cancer, Invited Speaker. Conference. New Advances in Breast Cancer, Invited Speaker. Houston, TX, US.
2015. Reducing Instrument Waste for Breast Cancer Surgery Cases (Poster Presentation). Conference. Reducing Instrument Waste for Breast Cancer Surgery Cases (Poster Presentation). Houston, TX, US.
2015. Approach to Increasing Autologous Reconstruction. Conference. Approach to Increasing Autologous Reconstruction. Houston, TX, US.
2014. Is Breast Conservation for Everyone?, Invited Speaker. Conference. Is Breast Conservation for Everyone?, Invited Speaker. Houston, TX, US.
2013. Targeted Axillary Dissection, Invited Speaker. Conference. Targeted Axillary Dissection, Invited Speaker. Houston, TX, US.
2013. Image Guided Surgery: A Surgeon's Perspective, Invited Speaker. Conference. Image Guided Surgery: A Surgeon's Perspective, Invited Speaker. Houston, TX, US.

Regional Presentations

2019. Leveraging Community Tumor Boards to Disseminate New Knowledge. Conference. Leveraging Community Tumor Boards to Disseminate New Knowledge. San Francisco, CA, US.

National Presentations

2022. Procedural Medical Operations. Conference. Procedural Medical Operations. Houston, TX, US.
2021. Axillary Management after Neoadjuvant Chemotherapy. Conference. Axillary Management after Neoadjuvant Chemotherapy.
2021. Why the clip matters. Conference. Why the clip matters.
2021. Axillary Management after Neoadjuvant Chemotherapy. Conference. Axillary Management after Neoadjuvant Chemotherapy, US.
2021. Targeted Axillary Dissection – De-scalating Axillary Surgery after Neoadjuvant Chemotherapy. Conference. Targeted Axillary Dissection – De-scalating Axillary Surgery after Neoadjuvant Chemotherapy, US.
2021. Dissemination & Implementation Science: Closing the Gap Between research and Clinical Practice. Conference. Dissemination & Implementation Science: Closing the Gap Between research and Clinical Practice, US.
2021. Localisation Techniques for the Future. Conference. Localisation Techniques for the Future, US.
2021. Overview of San Antonio Breast Conference – Axillary Management. Conference. Nebraska Oncology Society, US.
2020. Targeted Axillary Dissection. Conference. Targeted Axillary Dissection, US.
2020. Axillary Management after Neoadjuvant Chemotherapy. Conference. Axillary Management after Neoadjuvant Chemotherapy, US.
2020. The MD Anderson Experience with TAD. Conference. The MD Anderson Experience with TAD, US.
2020. Innovations in Breast Cancer Surgery. Conference. Innovations in Breast Cancer Surgery. Steamboat Springs, CO, US.
2019. How Local Tumor Boards Can Facilitate Implementation of Clinical Trial Results. Conference. How Local Tumor Boards Can Facilitate Implementation of Clinical Trial Results. Washington, DC, US.
2019. Sentinel Node Biopsy after Neoadjuvant Chemotherapy: Principles and Techniques. Conference. Sunrise Workshop Invited Speaker. Dallas, TX, US.
2019. Surgical Management of Breast Cancer. Conference. Surgical Management of Breast Cancer. Houston, TX, US.
2019. Innovation Ramps, not Roadblocks, to Speed Review of New Devices and Procedures. Conference. Refereed Presentation. San Diego, CA, US.
2019. Riding Out the Storm: Managing Operations in the Wake of Disaster. Conference. Refereed Presentation. San Diego, CA, US.
2018. Leveraging Community Tumor Boards for Oncology Trial Dissemination. Conference. Poster Presentation. Washington, DC, US.
2018. Tumor Board Video Series: A Pilot Program from the Alliance Dissemination & Implementation Committee. Conference. Tumor Board Video Series: A Pilot Program from the Alliance Dissemination & Implementation Committee. Boston, MA, US.
2018. Dissemination & Implementation: Accelerating Evidence into Practice. Conference. Dissemination & Implementation: Accelerating Evidence into Practice. Chicago, IL, US.
2018. Novel Approaches to SLN Biopsy After Neoadjuvant Therapy. Conference. Novel Approaches to SLN Biopsy After Neoadjuvant Therapy. Steamboat Springs, CO, US.
2018. Surgical Management of Triple Negative Breast Cancer. Conference. Surgical Management of Triple Negative Breast Cancer. Phoenix, AZ, US.
2018. Targeted Axillary Dissection: Management of Node Positive Disease After Neoadjuvant Therapy. Conference. Targeted Axillary Dissection: Management of Node Positive Disease After Neoadjuvant Therapy. Phoenix, AZ, US.
2018. Image Guided Surgery: A Surgeons Perspective. Conference. Image Guided Surgery: A Surgeons Perspective. Phoenix, AZ, US.
2017. Axillary Surgery after Neoadjuvant Chemotherapy. Conference. Axillary Surgery after Neoadjuvant Chemotherapy. Edinburgh, TX, US.
2017. New Frontiers in Breast Cancer. Conference. New Frontiers in Breast Cancer. Edinburgh, TX, US.
2017. Use of Sentinel Lymph Node Dissection after Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at diagnosis: Practice Patterns of American Society of Breast Surgeons Members. Conference. Refereed Presentation. Las Vegas, NV, US.
2017. Factors Impacting the Accuracy of Targeted Axillary Dissection. Conference. Refereed Presentation. Seattle, WA, US.
2017. Radiation and Breast Reconstruction – An Oncologist’s Perspective. Conference. Radiation and Breast Reconstruction – An Oncologist’s Perspective. Waikoloa, HI, US.
2016. Management of the Axilla after Neoadjuvant Chemotherapy. Conference. Management of the Axilla after Neoadjuvant Chemotherapy. Chappaqua, NY, US.
2016. A Surgeon's View: Nodal Evaluation After Neoadjuvant Chemotherapy. Conference. A Surgeon's View: Nodal Evaluation After Neoadjuvant Chemotherapy. Asheville, NC, US.
2016. Image Guided Surgery: The Surgeon's Perspective. Conference. Image Guided Surgery: The Surgeon's Perspective. Asheville, NC, US.
2016. New Frontiers in Surgical Oncology. Conference. New Frontiers in Surgical Oncology. Asheville, NC, US.
2016. Management of the Axilla after Neoadjuvant Chemotherapy. Conference. Management of the Axilla after Neoadjuvant Chemotherapy. Dallas, TX, US.
2015. Surgical Issue in Early Stage Breast Cancer. Conference. Surgical Issue in Early Stage Breast Cancer. Atlanta, GA, US.
2015. Targeted Axillary Dissection Improves Axillary Evaluation following Neoadjuvant Chemotherapy in Node Positive Patients. Conference. Targeted Axillary Dissection Improves Axillary Evaluation following Neoadjuvant Chemotherapy in Node Positive Patients. Houston, TX, US.
2014. Management of Axillary Disease. Conference. Management of Axillary Disease. Grapevine, TX, US.
2014. Breast Tumor Board. Conference. Breast Tumor Board. Grapevine, TX, US.
2014. Controversies in Breast Cancer Screening. Conference. Controversies in Breast Cancer Screening. Columbus, OH, US.
2013. Image Guided Surgery: The Surgeon's Perspective. Conference. Image Guided Surgery: The Surgeon's Perspective. Asheville, NC, US.
2013. Targeted Surgery for the Axilla in Early Breast Cancer Patients. Conference. Targeted Surgery for the Axilla in Early Breast Cancer Patients. Miami, FL, US.
2012. American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns. Conference. American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns. Phoenix, AZ, US.
2012. The Identification of Internal Mammary Sentinel Lymph Node Metastasis Impacts Therapy in Breast Cancer. Conference. Poster Presentation. Phoenix, AZ, US.
2010. Mitotic Rate Predicts Sentinel Lymph Node Involvement in Cutaneous Melanoma Impact of the 7th Edition AJCC Melanoma Staging System. Conference. Mitotic Rate Predicts Sentinel Lymph Node Involvement in Cutaneous Melanoma Impact of the 7th Edition AJCC Melanoma Staging System. St. Louis, MO, US.
2009. Impact of Progression during Neoadjuvant Chemotherapy on Operative Management of Breast Cancer. Conference. Poster Presentation. San Antonio, TX, US.
2009. Differential Regulation of EGFR by IL-24 in Melanoma. Conference. Poster Presentation. Denver, CO, US.
2008. Feasibility of Synchronous Resection of Primary and Metastatic Carcinoid Tumors. Conference. Poster Presentation. Chicago, IL, US.
2007. Colorectal Liver Metastasis Have Increased HER2, Amphiregulin, and Epiregulin Expression Which May Offer Therapeutic Targets. Conference. Poster Presentation. Baltimore, MD, US.
2007. Occult Pathologic Findings in Prophylactic Mastectomy Specimens. Conference. Poster Presentation. Phoenix, AZ, US.
2007. Increased Amphiregulin and Epiregulin Expression in Colorectal Tumors May Explain Clinical Response to EGFR-targeted Antibody Therapy. Conference. Poster Presentation. Washington, DC, US.
2006. Colorectal Adenocarcinomas Have Increased EGFR Ligand Expression. Conference. Colorectal Adenocarcinomas Have Increased EGFR Ligand Expression, US.
2006. Colorectal Adenocarcinomas Have Increased EGFR Ligand Expression. Conference. Surgery Grand Rounds. Chapel Hill, NC, US.
2006. Colorectal Adenocarcinomas Have Increased EGFR Ligand Expression. Conference. Poster Presentation. Baltimore, MD, US.
2006. Diabetes Decreases Response to Neoadjuvant Therapy in Rectal Cancer. Conference. Poster Presentation. San Diego, CA, US.
2006. Experienced Radio-Guided Surgery Teams Can Successfully Perform Minimally Invasive Parathyroidectomy Without Intraoperative Parathyroid Hormone Assays, Refereed Presentation. Conference. Experienced Radio-Guided Surgery Teams Can Successfully Perform Minimally Invasive Parathyroidectomy Without Intraoperative Parathyroid Hormone Assays, Refereed Presentation. Orlando, FL, US.
2005. Experienced Radio-Guided Surgery Teams Can Successfully Perform Minimally Invasive Parathyroidectomy Without Intraoperative Parathyroid Hormone Assays. Conference. Refereed Presentation. Chapel Hill, NC, US.
2005. Preoperative Radiotherapy in the Multidisciplinary Treatment of Retroperitoneal. Conference. Poster Presentation. Atlanta, GA, US.
2005. Making the Diagnosis of Peritoneal Tuberculosis. Conference. Poster Presentation. New Orleans, LA, US.
2004. Successful Minimally Invasive Parathyroidectomy Without Intra-Operative. Conference. Poster Presentation. New York, NY, US.

International Presentations

2021. The importance of Clipping Nodes. Conference. The importance of Clipping Nodes.
2021. De-Escalation of Axillary Surgery with Targeted Axillary Dissection. Conference. De-Escalation of Axillary Surgery with Targeted Axillary Dissection.
2021. International Perspective on Targeted Axillary Dissection, Invited Speaker. Conference. International Perspective on Targeted Axillary Dissection, Invited Speaker. Essen, DE.
2019. Axillary Management after Neoadjuvant Chemotherapy. Conference. Axillary Management after Neoadjuvant Chemotherapy. Saó Paulo, BR.
2019. Debate: Despite ACOSOG Z11 and AMAROS, there is still a role for axillary surgery with a positive sentinel node: YES. Conference. Debate: Despite ACOSOG Z11 and AMAROS, there is still a role for axillary surgery with a positive sentinel node: YES. San Francisco, US.
2019. Image-Guided Surgery: The Surgeon’s Perspective. Conference. Image-Guided Surgery: The Surgeon’s Perspective. Saó Paulo, BR.
2019. Surgery in Triple Negative Breast Cancer. Conference. Surgery in Triple Negative Breast Cancer. Saó Paulo, BR.
2019. The Case for Seed Localization. Conference. The Case for Seed Localization. San Francisco, US.
2019. Magseed Localization for the Breast and Axilla. Conference. Magseed Localization for the Breast and Axilla. San Francisco, US.
2019. Technology Advances in Breast Cancer. Conference. Technology Advances in Breast Cancer. Bogota, CO.
2019. Surgery in Stage IV Breast Cancer. Conference. Surgery in Stage IV Breast Cancer. Bogota, CO.
2019. Targeted Axillary Dissection with Magseed. Conference. Targeted Axillary Dissection with Magseed. Paris, FR.
2018. Fundamentals of Oncoplastic Surgery. Conference. Fundamentals of Oncoplastic Surgery. Manila, PH.
2018. Multidisciplinary Breast Cancer Conference. Conference. Multidisciplinary Breast Cancer Conference. Manila, PH.
2018. Targeted Axillary Dissection in Breast Cancer Patients. Conference. Targeted Axillary Dissection in Breast Cancer Patients. Merida, MX.
2018. Targeted Axillary Dissection: Improved Axillary Staging after Neoadjuvant Chemotherapy. Conference. Targeted Axillary Dissection: Improved Axillary Staging after Neoadjuvant Chemotherapy. Melbourne, AU.
2018. Axillary Surgery after Neoadjuvant Chemotherapy. Conference. Axillary Surgery after Neoadjuvant Chemotherapy. Zhijiazhuang, CN.
2018. Management of the Axilla: A Surgical Perspective. Conference. Management of the Axilla: A Surgical Perspective. San Diego, US.
2018. Novel Approaches to the Axilla After Neoadjuvant Chemotherapy. Conference. Novel Approaches to the Axilla After Neoadjuvant Chemotherapy, GB.
2017. Breast Conservation Therapy in Triple Negative Breast Cancer. Conference. Breast Conservation Therapy in Triple Negative Breast Cancer. Santo Domingo, DO.
2017. Current Guideline for Margin Status. Conference. Current Guideline for Margin Status. Cartegena, CO.
2017. Breast Conservation Therapy after Neoadjuvant Chemotherapy. Conference. Breast Conservation Therapy after Neoadjuvant Chemotherapy. Cartagena, CO.
2017. Axillary Management after Neoadjuvant chemotherapy. Conference. Axillary Management after Neoadjuvant chemotherapy. Cartagena, CO.
2017. All Patients with Node Positive Disease Before Neoadjuvant Chemotherapy Do Not Need ALND. Conference. All Patients with Node Positive Disease Before Neoadjuvant Chemotherapy Do Not Need ALND. Tokyo, JP.
2017. Axillary Assessment Should not be Mandatory for Patients with Invasive Breast Cancer. Conference. Axillary Assessment Should not be Mandatory for Patients with Invasive Breast Cancer. Tokyo, JP.
2017. Beyond Modified Radical Mastectomy. Conference. Beyond Modified Radical Mastectomy. Manila, PH.
2017. New Directions in Breast Surgical Oncology. Conference. New Directions in Breast Surgical Oncology. Manila, PH.
2017. Axillary Surgery After Neoadjuvant Therapy. Conference. Axillary Surgery After Neoadjuvant Therapy. Nottingham, GB.
2017. Image-Guided Surgery--A Surgeon's Prospective. Conference. Image-Guided Surgery--A Surgeon's Prospective. Beijing, CN.
2016. Surgical Management of the Axilla after Neoadjuvant Therapy. Conference. Surgical Management of the Axilla after Neoadjuvant Therapy. Santo Domingo, DO.
2016. Is Targeted Axillary Dissection for Everyone?. Conference. Is Targeted Axillary Dissection for Everyone?. Athens, GR.
2016. Breast Conserving Surgery after Neoadjuvant Treatment. Conference. Breast Conserving Surgery after Neoadjuvant Treatment. Santo Domingo, DO.
2016. Surgical Management of Node Positive Breast Cancer. Conference. Surgical Management of Node Positive Breast Cancer. Queretaro, MX.
2016. Update of ACOSOG Z0011. Conference. Update of ACOSOG Z0011. Cancun, MX.
2016. Best of SSO Breast Abstracts. Conference. Best of SSO Breast Abstracts. Cancun, MX.
2016. Multidisciplinary Management of Breast Cancer Patients with 1-3 Positive Nodes. Conference. Multidisciplinary Management of Breast Cancer Patients with 1-3 Positive Nodes. Cancun, MX.
2016. Surgical Management of the Axilla with Neoadjuvant Chemotherapy. Conference. Surgical Management of the Axilla with Neoadjuvant Chemotherapy. Beijing, CN.
2016. Optimizing surgical instrument sets for cases involving breast and plastic surgeons. Conference. Poster Presentation. Phoenix, US.
2015. Targeted Axillary Dissection Improves Axillary Evaluation following Neoadjuvant Chemotherapy in Node Positive Patients. Conference. Poster Presentation; Best Poster Session. Nice, FR.
2015. Targeted Axillary Dissection Improves Axillary Evaluation Following Neoadjuvant Chemotherapy in Node Positive Patients. Conference. Targeted Axillary Dissection Improves Axillary Evaluation Following Neoadjuvant Chemotherapy in Node Positive Patients. Nice, FR.
2015. Using the Biology of DCIS in Therapy. Conference. Invited Speaker, Roche International Educational Program – Oncology. Houston, US.
2015. Role of Sentinel Node Dissection after Neoadjuvant Chemotherapy. Conference. Invited, Speaker, Roche International Educational Program – Oncology. Houston, US.
2015. Surgical Management of the Breast and Axilla after Neoadjuvant Chemotherapy. Conference. Past, Present and Future of Breast Cancer Treatment. Medellin, CO.
2015. Surgical Approach to Triple Negative Breast Cancer. Conference. Past, Present and Future of Breast Cancer Treatment, Instituto de Cancerologia. Medellin, CO.
2015. Ductal Carcinoma in SITU: Does Biology Affect Management?. Conference. 2nd Encontro Internacional do Instituto COI. Rio de Janeiro, BR.
2015. Which is The Best Practice Regarding Axillary Management After Neoadjuvant Chemotherapy?. Conference. 2nd Encontro Internacional do Instituto COI. Rio de Janeiro, BR.
2015. Techniques for Image Guided Surgery. Conference. Techniques for Image Guided Surgery. Mersin, TR.
2015. Management of the Axilla after Chemotherapy. Conference. Management of the Axilla after Chemotherapy. Mersin, TR.
2015. Image-guided Breast Surgery: The Surgeon's Perspective. Conference. 2nd Encontro Internacional do Instituto COI. Rio de Janeiro, BR.
2015. Contralateral Mastectomy: Is It Here to Stay?. Conference. 2nd Encontro Internacional do Instituto COI. Rio de Janeiro, BR.
2014. Multidisciplinary Case Discussion of Breast Lesions. Conference. Multidisciplinary Case Discussion of Breast Lesions. Pattaya, TH.
2014. Improved Axillary Evaluation Following Neoadjuvant Chemotherapy for Node Positive Patients with Image-Guided Surgery. Conference. Poster Presentation. San Francisco, US.
2014. Targeted Axillary Dissection: New Targeted Surgical Approach to Selectively Remove Nodal Metastases in Breast Cancer. Conference. Targeted Axillary Dissection: New Targeted Surgical Approach to Selectively Remove Nodal Metastases in Breast Cancer. Budapest, HU.
2014. Controversies in Breast Cancer Screening. Conference. Controversies in Breast Cancer Screening. Al-Ahsa, SA.
2014. The Power of Percutaneous Breast Biopsy in Breast Cancer Diagnosis. Conference. The Power of Percutaneous Breast Biopsy in Breast Cancer Diagnosis. Al-Ahsa, SA.
2014. Percutaneous Biopsy of Breast Lesions. Conference. Health Care Global. Bangalore, IN.
2014. Imaging Guided Surgery. A Surgeon's Perspective. Conference. Health Care Global. Bangalore, IN.
2013. Predicting the Extent of Nodal Disease in Early Breast Cancer. Conference. Poster Presentation. San Francisco, US.
2011. Does the Biology of DCIS Affect Management?. Conference. Does the Biology of DCIS Affect Management?. Beirut, LB.
2009. Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer. Conference. Poster Presentation. Orlando, US.
2007. Measuring the Epidermal Growth Factor Receptor and its Ligands in Paraffin-Embedded Archived Patient Samples. Conference. Poster Presentation. Orlando, US.

Formal Peers

2019. New Techniques in Breast Cancer Surgery. Invited. Atlanta, GA, US.
2019. Breast Cancer Staging. Invited. Atlanta, GA, US.
2017. Advances in Surgical Management of the Axilla. Invited. Guangzhou, CN.
2015. Targeted Axillary Dissection – Improved Axillary Staging after Neoadjuvant Chemotherapy. Invited. Louisville, KY, US.
2015. Starting a Radioactive Seed Program. Invited. Louisville, KY, US.
2014. Personalized Axillary Surgery in Breast Cancer. Invited. Mount Laurel, NJ, US.
2014. Controversies in Breast Cancer Screening. Invited. Columbus, OH, US.
2014. Building a Preparation for Life. Invited. Charlotte, NC, US.
2013. Advances in Targeted Breast Surgery. Invited, US.
2012. Surgical Issues with Neoadjuvant Chemotherapy. Invited. Hangzhou, CN.
2012. Management of the Axilla in Early Breast Cancer: A Modern Perspective. Invited. Hangzhou, CN.
2012. American College of Surgeons Oncology Group (ACOSOG) Z0011 Trial: A Practice-Changing Trial. Invited. Cape Girardeau, MO, US.
2012. Surgical Issues Associated with Neoadjuvant Chemotherapy in Breast Cancer. Invited. Odessa, TX, US.
2011. American College of Surgeons Oncology Group (ACOSOG) Z0011 Trial: A Practice-Changing Trial. Invited. Cape Girardeau, MO, US.
2010. Management of Metastatic Melanoma: Hope for the New Frontier. Invited. Houston, TX, US.

Less

Grant & Contract Support

Date:	2024 - 2024
Title:	Innovating Breast Cancer RNA therapy: Mechanisms and Pharmaco-genetic Inhibitors
Funding Source:	DOD/Congressionally Directed Medical Research Programs (DOD/CDMRP)
Role:	Co-I
ID:	BC230333

Date:	2018 - 2019
Title:	Co-Targeting the LncRNA-PIP3 Interaction and AKT/PI3K Signaling Axis: A Novel Paradigm for treating Triple-negative Breast Cancer
Funding Source:	NIH/NCI
Role:	Collaborator

Date:	2017 - 2019
Title:	A Prospective Open Label Study of Use of Magseed and Sentimag to Localize Axillary Lymph Nodes with Biopsy- proven Metastases in Breast Cancer Patients
Funding Source:	MDACC High Impact Clinical Research Support Program (HI-CRSP)
Role:	PI

Date:	2016 - 2019
Title:	Co-Targeting the LncRNA-PIP3 Interaction and AKT/PI3K Signaling Axis: A Novel Paradigm for treating Triple-Negative Breast Cancer
Funding Source:	Department of Defense (DOD)
Role:	Co-I

Date:	2016 - 2021
Title:	Comparative Effectiveness Research on Cancer in Texas (CERCIT) 2.0: Project 3
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-I

Date:	2015 - 2017
Title:	Targeted Axillary Dissection - A Novel Surgical Approach to Accurately Assess Response to Preoperative Chemotherapy in Clinical Node Positive Breast Cancer Patients
Funding Source:	Institutional Clinical Innovator Award Application
Role:	PI

Date:	2015 - 2015
Title:	Targeted Axillary Dissection: A Novel Surgical Approach to Accurately Assess Response to Preoperative Chemotherapy in Clinically Node Positive Breast Cancer Patients
Funding Source:	Mike Hogg Foundation Award
Role:	PI

Date:	2008 - 2010
Title:	T32-Training Grant
Funding Source:	NIH
Role:	Trainee
ID:	CA09599

Date:	2005 - 2007
Title:	T32 Training Grant
Funding Source:	NIH/NCI
Role:	Trainee
ID:	CA09688-12

CV information above last modified May 06, 2025

Abigail S. Caudle, M.D., M.S., F.A.C.S., CMQ

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Other Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Invited Articles

Manuals, Teaching Aids, Other Teaching Publications

Other Articles

Abstracts

Book Chapters

Letters to the Editor

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Abigail S. Caudle, M.D., M.S., F.A.C.S., CMQ

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Other Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Invited Articles

Manuals, Teaching Aids, Other Teaching Publications

Other Articles

Abstracts

Book Chapters

Letters to the Editor

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Volunteer